NSCLC-EXOs contain Amphiregulin (AREG), an important EGFR ligand that induces EGFR pathway activation in pre-osteoclasts which, in turn, causes increased expression of RANKL. This evidence concerns the gene EGFR and non-small cell lung carcinoma.